Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM5 | P08912 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.32 |
| ▸ | ADH1B | P00325 | 1/20 | 0.32 |
| ▸ | ADH1C | P00326 | 1/20 | 0.32 |
| ▸ | ADH1A | P07327 | 1/20 | 0.32 |
| ▸ | ADH4 | P08319 | 1/20 | 0.32 |
| ▸ | ADH7 | P40394 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4536358 | 0.72 | GABRA5 (0.37) | EPHX1 | |
| SCHEMBL3886447 | 0.72 | CYP1A2 (0.42) | CHRM5CYP1A2ADRA2CCHRM2CHRM4 | |
| SCHEMBL5463728 | 0.71 | CHRM5 (0.35) | CHRM5CYP1A2ADRA2CCHRM2CHRM4 | |
| SCHEMBL446739 | 0.71 | CHRM5 (0.35) | CHRM5CYP1A2ADRA2CCHRM2CHRM4 | |
| SCHEMBL15091573 | 0.71 | CHRM5 (0.35) | CHRM5CYP1A2ADRA2CCHRM2CHRM4 | |
| SCHEMBL15091601 | 0.71 | CHRM5 (0.35) | CHRM5CYP1A2ADRA2CCHRM2CHRM4 | |
| SCHEMBL15091738 | 0.71 | CHRM5 (0.35) | CHRM5CYP1A2ADRA2CCHRM2CHRM4 | |
| SCHEMBL17138312 | 0.71 | CHRM5 (0.35) | CHRM5CYP1A2ADRA2CCHRM2CHRM4 | |
| SCHEMBL29030426 | 0.71 | CYP1A2 (0.40) | CHRM5CYP1A2ADRA2CCHRM2CHRM4 | |
| SCHEMBL28585886 | 0.67 | CYP1A2 (0.42) | CHRM5CYP1A2ADRA2CCHRM2CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9884879-B2 | Method of synthesizing siloxane monomers and use thereof | SILECS OY (FI) | 2018-02-06 | — | — | US | claimed |
| US-20170088565-A1 | Method of synthesizing siloxane monomers and use thereof | SILECS OY (FI) | 2017-03-30 | — | — | US | claimed |
| US-20140249326-A1 | Method of Synthesizing Siloxane Monomers and Use Thereof | SILECS OY (FI) | 2014-09-04 | — | — | US | claimed |
| WO-2012172176-A9 | METHOD OF SYNTHESIZING SILOXANE MONOMERS AND USE THEREOF | SILECS OY (FI) | 2013-02-07 | — | — | WO | claimed |
| WO-2012172176-A2 | METHOD OF SYNTHESIZING SILOXANE MONOMERS AND USE THEREOF | SILECS OY (FI) | 2012-12-20 | — | — | WO | claimed |
| US-9884879-B2 | Method of synthesizing siloxane monomers and use thereof | SILECS OY (FI) | 2018-02-06 | — | — | US | disclosed |
| US-20170088565-A1 | Method of synthesizing siloxane monomers and use thereof | SILECS OY (FI) | 2017-03-30 | — | — | US | disclosed |
| US-9458183-B2 | Method of synthesizing siloxane monomers and use thereof | SILECS OY (FI) | 2016-10-04 | — | — | US | disclosed |
| EP-2805999-A1 | Photosensitive Alkali-Soluble Silicone Resin Composition | Asahi Kasei E-materials Corporation (JP) | 2014-11-26 | — | — | EP | disclosed |
| US-20140249326-A1 | Method of Synthesizing Siloxane Monomers and Use Thereof | SILECS OY (FI) | 2014-09-04 | — | — | US | disclosed |
| US-20140193632-A1 | PHOTOSENSITIVE ALKALI-SOLUBLE SILICONE RESIN COMPOSITION | ASAHI KASEI E-MATERIALS CORPORATION (JP) | 2014-07-10 | — | — | US | disclosed |
| EP-2752712-A1 | PHOTOSENSITIVE ALKALI-SOLUBLE SILICONE RESIN COMPOSITION | Asahi Kasei E-Materials Corporation (JP) | 2014-07-09 | — | — | EP | disclosed |
| US-6652608-B1 | Fuel compositions exhibiting improved fuel stability | OCTANE INTERNATIONAL, LTD. | 2003-11-25 | — | — | US | disclosed |
| US-20020086235-A1 | Lithography | EASTMAN KODAK COMPANY | 2002-07-04 | — | — | US | disclosed |
| US-6399271-B1 | HYDROXY CONTAINING COMPOUND WITH AFFINITY FOR INK, AND TITANIUM OR SILICON CONTAINING COMPOUND WITH DIFFERENT AFFINITY FOR INK | KODAK POLYCHROME GRAPHICS LLC | 2002-06-04 | — | — | US | disclosed |
| EP-1051461-A2 | FUEL COMPOSITIONS EMPLOYING CATALYST COMBUSTION STRUCTURE | ORR, William C. (US) | 2000-11-15 | — | — | EP | disclosed |
| WO-1999066009-A2 | FUEL COMPOSITIONS EMPLOYING CATALYST COMBUSTION STRUCTURE | ORR WILLIAM C (US) | 1999-12-23 | — | — | WO | disclosed |
| EP-0954558-A1 | FUEL COMPOSITIONS EXHIBITING IMPROVED FUEL STABILITY | ORR, William C. (US) | 1999-11-10 | — | — | EP | disclosed |
| WO-1998026028-A1 | FUEL COMPOSITIONS EXHIBITING IMPROVED FUEL STABILITY | ORR WILLIAM C (US) | 1998-06-18 | — | — | WO | disclosed |
| EP-0377175-A2 | Pattern forming composition and process for forming pattern using the same | HITACHI, LTD. (JP) | 1990-07-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170088565-A1 | Method of synthesizing siloxane monomers and use thereof | MSMO1, PCNA, PIEZO1 | CHRM5 2449/4885CYP1A2 421/4885ADRA2C 4544/4885 |
| US-20140249326-A1 | Method of Synthesizing Siloxane Monomers and Use Thereof | MSMO1, PCNA, PIEZO1 | CHRM5 2449/4885CYP1A2 421/4885ADRA2C 4544/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.